BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15072071)

  • 1. Commerce in organs: a Kantian critique.
    Morelli M
    J Soc Philos; 1999; 30(2):315-24. PubMed ID: 15072071
    [No Abstract]   [Full Text] [Related]  

  • 2. Organ sales and moral distress.
    Rivera-Lopez E
    J Appl Philos; 2006; 23(1):41-52. PubMed ID: 16683325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commerce in organ transplantation.
    Lu L
    Pharos Alpha Omega Alpha Honor Med Soc; 1998; 61(2):2-5. PubMed ID: 9637866
    [No Abstract]   [Full Text] [Related]  

  • 4. Why not a kidney market? An obvious solution to the organ shortage.
    Taylor JS
    Free Inq; 2005; 25(5):42-3. PubMed ID: 16358474
    [No Abstract]   [Full Text] [Related]  

  • 5. Why we should not pay for human organs.
    Delmonico FL; Scheper-Hughes N
    Natl Cathol Bioeth Q; 2002; 2(3):381-9. PubMed ID: 12854595
    [No Abstract]   [Full Text] [Related]  

  • 6. The case against kidney sales.
    George T
    Issues Med Ethics; 2001; 9(2):49-50. PubMed ID: 16334471
    [No Abstract]   [Full Text] [Related]  

  • 7. The case for commerce in organ transplantation.
    Blumstein JF
    Transplant Proc; 1992 Oct; 24(5):2190-7. PubMed ID: 1413027
    [No Abstract]   [Full Text] [Related]  

  • 8. Bodily integrity and the sale of human organs.
    Wilkinson S; Garrard E
    J Med Ethics; 1996 Dec; 22(6):334-9. PubMed ID: 8961117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The body as property: some philosophical reflections.
    Childress JF
    Transplant Proc; 1992 Oct; 24(5):2143-8; discussion 2149-51. PubMed ID: 1413014
    [No Abstract]   [Full Text] [Related]  

  • 10. Imposing options on people in poverty: the harm of a live donor organ market.
    Rippon S
    J Med Ethics; 2014 Mar; 40(3):145-50. PubMed ID: 22745109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The commodification of human reproductive materials.
    Resnik DB
    J Med Ethics; 1998 Dec; 24(6):388-93. PubMed ID: 9873979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autonomy, moral constraints, and markets in kidneys.
    Kerstein SJ
    J Med Philos; 2009 Dec; 34(6):573-85. PubMed ID: 19846479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scholarly watchdogs for an ethical netherworld: researchers form group to track and study sale of body parts for organ transplants.
    Monaghan P
    Chron High Educ; 2000 Oct; 47():A23-4. PubMed ID: 14598856
    [No Abstract]   [Full Text] [Related]  

  • 14. Organ markets and the ends of medicine.
    Davis FD; Crowe SJ
    J Med Philos; 2009 Dec; 34(6):586-605. PubMed ID: 19880547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconsidering Kantian arguments against organ selling.
    Alpinar-Şencan Z
    Med Health Care Philos; 2016 Mar; 19(1):21-31. PubMed ID: 25637083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the sale of body parts wrong?
    Savulescu J
    J Med Ethics; 2003 Jun; 29(3):138-9. PubMed ID: 12796429
    [No Abstract]   [Full Text] [Related]  

  • 17. Introduction: symposium on a regulated market in transplantable organs.
    Hippen BE
    J Med Philos; 2009 Dec; 34(6):545-51. PubMed ID: 19846477
    [No Abstract]   [Full Text] [Related]  

  • 18. Selling organs and souls: should the state prohibit 'demeaning' practices?
    Wilkinson DJ
    J Bioeth Inq; 2004; 1(1):27-31. PubMed ID: 16025595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. U.K. bioethics, U.K. metabioethics: organ sales and the justification of bioethical methods.
    Herissone-Kelly P
    Camb Q Healthc Ethics; 2004; 13(3):226-35. PubMed ID: 15283545
    [No Abstract]   [Full Text] [Related]  

  • 20. Exchanging one hardship for another.
    Sharp LA
    Hastings Cent Rep; 2009; 39(3):3. PubMed ID: 19537608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.